ACTRN12613000200785尚未招募未知
In patients with low-risk acute coronary syndromes who undergo angioplasty and stenting, or medical therapy after coronary angiography, is early discharge (<72 hours) to ambulatory care as safe as conventional 4-5 day hospital stay with no increase in mortality, adverse events or unexpected readmission to hospital?
Cardiology Department Eastern Health0 个研究点目标入组 300 人开始时间: 2013年2月19日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit(—)
- 性别
- All
入选标准
- •Participants who suffer from heart attacks, over 18 years of age and are willing and able to sign informed consent forms
排除标准
- •Age < 18 years
- •Non-English speaking background patient without English speaking carer.
- •Significant medical co-morbidities such as severe COPD, pre-existing heart failure, poorly controlled diabetes, and moderate to severe renal impairment
- •Lesions that require further revascularization (ie. Staged PCI or CABG)
- •Other lesions that have >70% intra-luminal stenosis on coronary angiogram and are managed medically
- •Ejection Fraction <40%
- •Out of hospital cardiac arrest requiring >3 x DCRs, intubation or inotropic support
- •Unsuccessful or complicated PCI such as no reflow, temporary pacing and perforation.
- •Patients who develop non-cardiac complications within 24 hours after PCI: bleeding, stroke, acute renal impairment, vascular sequelae, groin hematoma >5cm diameter, active infection or sepsis
- •STEMI patients who receive thrombolysis prior to transfer to BHH
- •Resides >60km radius from Box Hill Hospital
- •Poor social support and pre-existing significant mobility or memory issue
- •History of illicit drug use
研究者
相似试验
已完成
3 期
The Australian COPS trial - COlchicine in Patients with acute coronary SyndromesIschaemic heart diseaseCardiovascular - Coronary heart diseaseACTRN12615000861550St. Vincent's Hospital Melbourne800
招募中
不适用
Clinical Pathways for Acute Coronary Syndromes in China - phase 2: implementation and evaluatioAcute Coronary SyndromesCardiovascular - Coronary heart diseaseACTRN12609000491268Sanofi-Aventis (China)15,000
尚未招募
不适用
Evaluation of an educational resource for cardiac secondary prevention: a randomised controlled trialAcute coronary syndromeCardiovascular - Coronary heart diseasePublic Health - Health promotion/educationACTRN12613000395730Deakin University100
尚未招募
4 期
Ticagrelor and platelet reactivity in acute coronary syndromesCardiovascular - Coronary heart diseaseAcute Coronary SyndromeACTRN12613001208796Peter Larsen50
已完成
不适用
The CHOICE (Choice of health options in prevention of cardiovascular events) replication trial.Acute coronary syndromeACTRN12608000182392ANZAC Research Institute, Concord Hospital500
